CN1057445C - Method for preparing anticancer bioactive peptide preparation - Google Patents
Method for preparing anticancer bioactive peptide preparation Download PDFInfo
- Publication number
- CN1057445C CN1057445C CN96122236A CN96122236A CN1057445C CN 1057445 C CN1057445 C CN 1057445C CN 96122236 A CN96122236 A CN 96122236A CN 96122236 A CN96122236 A CN 96122236A CN 1057445 C CN1057445 C CN 1057445C
- Authority
- CN
- China
- Prior art keywords
- preparation
- bioactive peptide
- goat
- multigelation
- normal saline
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
The present invention relates to a preparation method for preparing anticancer bioactive peptides, which uses the cell-free extracting solution of human cancer tissue to induce goat spleens to generate and proliferate active peptides, wherein prepared effective components are the cell-free extracting solution. The bioactive peptide preparation has the advantages of no toxic effect, side effect or antigenicity, can manoeuvre and restore the autoimmune function and the anticancer capability of tumour patients, has certain functions of selectively killing and inhibiting the proliferation and the transfer of tumor cells, and inducing the differentiation and the apoptosis of tumor cells and has no interference in normal physiological metabolism.
Description
The present invention relates to a kind of biologically active peptide, particularly its active ingredient is the preparation method of cell-free extract, and its method comprises through animal induces the generation bioactive peptide.
Abroad just have as far back as nineteen twenty-nine and to research and propose spleen and can produce a kind of factor that suppresses tumor growth, and studied the role and influence that development takes place for stomach cancer cell peptide.What relevant both at home and abroad research was adopted all is Placenta Hominis or serum peptide.Do not see reported in literature about animal spleen induced activity peptide and basis and clinical experiment.
The preparation method that the purpose of this invention is to provide a kind of anticancer bioactive peptide can prepare a kind of transfer in this way, recover tumor patient autoimmune function and anti-cancer ability and the preparation that has no side effect.
The objective of the invention is to finish: extract human body cancer tissue earlier by following measure, again itself and normal saline are pulverized in the ratio of 0.5~1g/ml, even oar, multigelation three times, centrifugal treating 15~20 minutes (3000 rev/mins), get the acellular liquid in upper strata goat is carried out multidigit point (back, foot) subcutaneous inducing injected 3~5 times, after injection is last, after 3~5 days the goat arterial blood letting is put extremely, take out Lien Naemorhedi rapidly, liver, thymus is pulverized fast, itself and normal saline are made even oar in 0.5~1g/4ml ratio, put under the cryogenic conditions multigelation three times, more after filtration, centrifugal, ultrafiltration, degerming becomes finished product.
Advantage of the present invention and effect are: preparation method adopts gentle process and comparatively simple, and preparation liquid only contains normal saline, does not contain pungent.Temperature is not had strict demand, need not the special reagent preparation yet.The bioactive peptide that extracts from the animal spleen with specific function is a kind of cell-free extract, has no side effect no antigen, but life-time service.
This preparation had both possessed used clinically cytokines class material at present, killed and wounded the advantage that suppresses tumor cell as interferon, interleukin etc., has again normal cell is not had lethality, strengthened to recover body's immunity; The inducing tumor cell differentiation, the function that enters apoptosis.
Clinical voluntary requirement is accepted to use the back with tens routine late tumor patients of bioactive peptide treatment to be observed, the confirmation bioactive peptide has transfer, recovery patient's autoimmune function and kills and wounds, suppresses the function of tumor cell proliferation, transfer, improve patient's life quality, prolonged patient's vital stage.
This accompanying drawing is the flow chart of this preparation method;
Embodiment: (cancerous tissue: ratio normal saline) is pulverized in 1g/ml with human cancer tissue, even oar multigelation three times, 3000 rev/mins centrifugal 20 minutes, get the acellular liquid in upper strata and goat is carried out multidigit point (back, foot step) is subcutaneous induces injection, each 10 days at interval, induce injection, coinduction 5 times, after the 5th injection, the goat arterial blood letting is put extremely after 3 days.
Relatively under the aseptic condition, take out spleen, liver, thymus rapidly, and pulverize fast, pulverize the back tissue in the (tissue fluid: normal saline) make even oar, put under the cryogenic conditions multigelation three times of 1g/4ml ratio.Freeze thawing liquid filters through multilamellar sterile gauze (more than 20 layers), get filtered solution and carry out ultracentrifugation, 10000 rev/mins 20 minutes.
Learn from else's experience supernatant liquid after centrifugal at room temperature filters through CA-110 dialyser (U.S. Baxter company).
Filtered solution is encapsulated into finished product through 0.2 μ disposable filter degerming.
Claims (1)
1, a kind of preparation method of anticancer bioactive peptide preparation, its method comprises through animal induces the generation bioactive peptide, it is characterized in that extracting earlier human body cancer tissue, again itself and normal saline are pulverized in the ratio of 0.5-1g/ml, even oar, multigelation three times, centrifugal treating 15-20 minute, 3000 rev/mins, get the acellular liquid in upper strata goat is carried out the back, subcutaneous the inducing of foot multidigit point injected 3-5 time, after injection is last, after 3-5 days the goat arterial blood letting is put extremely, take out Lien Naemorhedi rapidly, liver, thymus is pulverized fast, itself and normal saline are made even oar in the 0.5-1g/4ml ratio, multigelation is three times under cryogenic conditions, more after filtration, centrifugal, ultrafiltration, degerming becomes finished product.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN96122236A CN1057445C (en) | 1996-11-04 | 1996-11-04 | Method for preparing anticancer bioactive peptide preparation |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN96122236A CN1057445C (en) | 1996-11-04 | 1996-11-04 | Method for preparing anticancer bioactive peptide preparation |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1159918A CN1159918A (en) | 1997-09-24 |
CN1057445C true CN1057445C (en) | 2000-10-18 |
Family
ID=5127191
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN96122236A Expired - Fee Related CN1057445C (en) | 1996-11-04 | 1996-11-04 | Method for preparing anticancer bioactive peptide preparation |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1057445C (en) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103319589B (en) * | 2013-04-23 | 2016-03-30 | 内蒙古医科大学附属医院 | A kind of preparation method suppressing the biologically active peptides of cancer of the stomach stem cells hyperplasia |
CN106167510A (en) * | 2016-03-11 | 2016-11-30 | 苏秀兰 | A kind of double selenium polypeptide and preparation method thereof |
CN106699865A (en) * | 2017-01-17 | 2017-05-24 | 李露青 | Anticancer active peptide variants and application thereof |
CN106699863A (en) * | 2017-01-17 | 2017-05-24 | 李露青 | Anticancer active peptide variants and application thereof |
CN106831970A (en) * | 2017-01-17 | 2017-06-13 | 李露青 | A kind of anticancer active peptide variant and its application |
CN106749592A (en) * | 2017-01-17 | 2017-05-31 | 李露青 | A kind of anticancer active peptide variant and its application |
CN106699864A (en) * | 2017-01-17 | 2017-05-24 | 李露青 | Antitumor bioactive peptide variant and application thereof |
CN106589093A (en) * | 2017-01-17 | 2017-04-26 | 李露青 | Anticancer bioactive peptide variant and application thereof |
CN106632639A (en) * | 2017-01-17 | 2017-05-10 | 李露青 | Anticancer active peptide variants and application thereof |
CN106589094A (en) * | 2017-01-17 | 2017-04-26 | 李露青 | Anti-cancer bioactive peptide variant and application thereof |
CN106589096A (en) * | 2017-01-17 | 2017-04-26 | 李露青 | Anticancer active peptide variant and application thereof |
CN106589097A (en) * | 2017-01-17 | 2017-04-26 | 李露青 | Anti-cancer bioactive peptide variant and application thereof |
CN106632638A (en) * | 2017-01-17 | 2017-05-10 | 李露青 | Peptide variants with anti-cancer activities and application thereof |
CN106589095A (en) * | 2017-01-17 | 2017-04-26 | 李露青 | Anticancer active peptide variant and application thereof |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1035772A (en) * | 1988-03-15 | 1989-09-27 | 庞健男 | The manufacturing process of cure compound for acne ulcer |
-
1996
- 1996-11-04 CN CN96122236A patent/CN1057445C/en not_active Expired - Fee Related
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1035772A (en) * | 1988-03-15 | 1989-09-27 | 庞健男 | The manufacturing process of cure compound for acne ulcer |
Also Published As
Publication number | Publication date |
---|---|
CN1159918A (en) | 1997-09-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1057445C (en) | Method for preparing anticancer bioactive peptide preparation | |
US5595743A (en) | Preparation of herbal medicines by using a multi-enzyme system, herbal medicines prepared and their uses | |
CN102309534B (en) | Chinese medicinal herb composition for treating burns and scalds, its preparation method and application | |
CN101279104A (en) | Preparation of collagen protein sponge containing growth factor | |
CN1121807A (en) | "Ailing" anticancer injection | |
CN104041636A (en) | Traditional Chinese medicine health scented tea capable of beautifying and losing weight | |
CN103690935A (en) | Freeze-drying medicine composition containing thymalfasin and preparation method of freeze-drying medicine composition | |
CN100448466C (en) | Medicine for preventing and adjuvant treating cancer and its preparation method | |
Bode et al. | Choleresis induced by secretin: distinctly increased response in cirrhotics | |
CN101676401B (en) | Scorpion extract | |
CN1102056C (en) | Plant night cream for treating pustular acne | |
CN1108809C (en) | Medicine for treating leukoderma and preparing process thereof | |
CN1203092A (en) | Anticancer oral liquor and its preparing process | |
RU2147239C1 (en) | General tonic nonspecific immunomodulating agent | |
CN1058624C (en) | Burns curing powder and its preparation | |
CN117398339B (en) | Sustained-release polypeptide for tumor patients after chemotherapy and preparation method and application thereof | |
CN107029215A (en) | A kind of stem cell medicine and its preparation method and application | |
CN103007260A (en) | Preparation method of medicine for rapidly healing burned tissue | |
CA2072020A1 (en) | Stimulator of vascular endothelial cells and use thereof | |
CN109692328A (en) | A kind of proteolytic enzyme preparation applied to treatment of cancer | |
CN1061892C (en) | Oral liquid for treating tumor | |
CN106138208A (en) | A kind of application compress treating chronic skin ulcer and preparation method thereof | |
CN1562154B (en) | Specific burn and scald medicine and preparing method | |
CN1277560C (en) | Sanhuang capsules and preparation thereof | |
CN103446207B (en) | Preparation method and application of reagent for activating human immune cells |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C19 | Lapse of patent right due to non-payment of the annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20001018 Termination date: 20141104 |
|
EXPY | Termination of patent right or utility model |